MORGAN STANLEY - CELLECT BIOTECHNOLOGY LTD ownership

CELLECT BIOTECHNOLOGY LTD's ticker is APOP and the CUSIP is 15116C201. A total of 3 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CELLECT BIOTECHNOLOGY LTD
ValueSharesWeighting
Q2 2021$20,000
+25.0%
5,2520.0%0.00%
Q1 2021$16,000
-27.3%
5,252
-48.8%
0.00%
Q4 2020$22,0000.0%10,2520.0%0.00%
Q3 2020$22,000
-12.0%
10,252
+28.6%
0.00%
Q2 2020$25,0007,9700.00%
Other shareholders
CELLECT BIOTECHNOLOGY LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Renaissance Technologies 115,564$433,0000.00%
UBS Group AG 8,213$31,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,200$38,0000.00%
MORGAN STANLEY 5,252$20,0000.00%
Citadel Advisors 16,034$60,0000.00%
HRT FINANCIAL LP 13,049$48,0000.00%
View complete list of CELLECT BIOTECHNOLOGY LTD shareholders